Back to search

Article

RANKOR: Direct Drug Prioritization from Bulk and Single-Cell Transcriptomic Signatures

2026-05-21

Abstract excerpt

<h4>Background</h4> Prioritizing therapeutics from transcriptomic data remains a key challenge in precision medicine. Signature reversal approaches, most commonly implemented through Gene Set Enrichment Analysis (GSEA), have been widely used to match disease signatures to candidate drugs. However, enrichment-based methods can be sensitive to noise and are restricted to previously profiled compounds <h4>Methods</h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0ca5eb2c-cf50-509c-81d0-95201f2d1480
DOI
10.64898/2026.05.20.726471
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RANKOR: Direct Drug Prioritization from Bulk and Single-Cell Transcriptomic SignaturesDOI 10.64898/2026.05.20.726471
Select a neighboring publication to make it the new centre.